PharmaLundensis AB

ABActive

Org 5567088074Scheelevägen 22, 223 63 LundResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2006 · 19 years old1-4 employees

Overview Financials People & ownership Related companies

PharmaLundensis AB is a Swedish AB based in Lund, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2006, the company reported revenue of SEK 0 in its latest annual filing.

Revenue 2024

SEK 0

EBITDA margin

—

Net profit 2024

SEK -3,6M

+18% vs 2023

Key ratios

See full ratios →

38.5%

This company

20202024

0.3×

This company

20202024

-36.0%

This company

20202024

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 0	—
EBITDA	SEK -2,2M	+23%
Net profit	SEK -3,6M	+18%
Total assets	SEK 10,1M	-8%
Equity	SEK 3,9M	+23%
Employees	—	—

Contact

Address

Scheelevägen 22, 223 63 Lund

Phone

+4646132778

staffan.skogvall@pharmalundensis.se

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of PharmaLundensis AB?

PharmaLundensis AB is registered with Bolagsverket / SCB under Org 5567088074.

Who is the CEO of PharmaLundensis AB?

Tord Staffan Håkan Skogvall is the CEO of PharmaLundensis AB, in role since 2020.

Who is the chairman of PharmaLundensis AB?

Björn Torsten Georg Sivik chairs the board of PharmaLundensis AB, in role since 2025.

Where is PharmaLundensis AB headquartered?

PharmaLundensis AB's registered address is Scheelevägen 22.

PharmaLundensis AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on PharmaLundensis AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on PharmaLundensis AB